Previous reports have shown hepatotoxicity without liver necrosis related to ribociclib.<h4>Case presentation</h4>A 41-year-old female patient with primary metastatic HR-positive, HER2-negative breast cancer developed liver enzyme elevation under treatment with ribociclib. The gene discussed is ERBB2; the disease is breast carcinoma.